David Gionco, Chief Accounting Officer at STEMLINE THERAPEUTICS INC (STML), sold 1,116 shares at $8.13 ($9K) on 2017-03-07, disclosed to the SEC on 2017-03-09.
Open-market sale of $9k STML by Chief Accounting Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| STML | SELL | 2020-03-13 | $69K | — | Filing → |
| STML | SELL | 2020-02-28 | $118K | — | Filing → |
| STML | SELL | 2020-01-03 | $49K | — | Filing → |